2nd Quarter - Report

COVIDIEN LP for COVIDIEN LP

Firm
Client
Income
—
Expenses
$510,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Issues related to free trade agreements in European Union and Asia.

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
WHITNEY GARDINER —
JOHN CHRISTOPHER KALAVRITINOS —
TIMOTHY MCBRIDE —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); SENATE; Commerce, Dept of (DOC); Natl Security Council (NSC)

Taxation/Internal Revenue Code TAX

S. 232: Medical Device Access and Innovation Protection Act (all provisions) ; H.R. 523: Protect Medical Innovation (all provisions); Issues related to the implementation of the Medical Device Tax; Issues related to the repeal of the Medical Device Tax; International tax on foreign direct investment; Corporate Tax Reform generally; S. 95: Student Loan Affordability Act of 2013 (provisions pertaining to international tax).S.2360/ H.R.4679 The Stop Corporate Inversions Act of 2014 (Provisions related to management and control); H.R.4985 - Stop Corporate Expatriation and Invest in America's Infrastructure Act of 2014 (Provisions related to management and control)

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
WHITNEY GARDINER —
JOHN CHRISTOPHER KALAVRITINOS —
TIMOTHY MCBRIDE —

Contacted: State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Natl Security Council (NSC); SENATE; U.S. Trade Representative (USTR)

Bills named: S. 2360 (113th), S. 232 (113th), S. 95 (113th), H.R. 4679 (113th), H.R. 523 (113th), H.R. 4985 (113th)

Economics/Economic Development ECN

H.R. 2052/S. 1023: Global Investments in American Jobs Act of 2013 (all provisions)

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
WHITNEY GARDINER —

Contacted: SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Natl Security Council (NSC); Commerce, Dept of (DOC)

Bills named: H.R. 2052 (113th), S. 1023 (113th)

Health Issues HCR

Issues relating to implementation of provisions of the Food and Drugs Administration Safety and Innovation Act related to device review; Issues related to sequestration of the FDA medical device user fees; Issues related to reimbursements for Transcutaneous Electronic Stimulation (TENS) therapy for chronic low back pain; Issue regarding the Hospital Outpatient Prospective Payment System and the proposed changes to the reimbursement of certain vascular procedures.Issues related to SGR legislation and the provision to create a CMS pilot program to encourage more home-based remote monitoring. Issues related to medicare coverage of early lung cancer screening.

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
WHITNEY GARDINER —
JOHN CHRISTOPHER KALAVRITINOS —
TIMOTHY MCBRIDE —

Contacted: Natl Security Council (NSC); HOUSE OF REPRESENTATIVES; SENATE; Commerce, Dept of (DOC); State, Dept of (DOS); U.S. Trade Representative (USTR)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.